Global Factor VIII Deficiency Treatment Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 101

Report ID: 3165

Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endothelial cells outside the liver across the body. This protein mixes in the bloodstream in an inactive form, and binds to another molecule called von Willebrand factor, until a damage to blood vessels occur. In response to injury, coagulation factor VIII gets activated and separates from von Willebrand factor.
The global hemophilia A drugs market segment accounted for the majority market share and will continue to dominate the factor 8 deficiency treatment market for the next few years. Some of the major factors responsible for the market segment's growth is the growing incidence of hemophilia A, the development of novel drugs with extended action, and the increased adoption of prophylactic treatment. Additionally, growing demand for novel recombinant extended half-life products, the emergence of monoclonal antibodies and gene therapy products, and launch of plasma-derived products for recombinant factor VIII at low costs, will also further drive the growth of the factor VIII deficiency treatment market.
In 2018, the global Factor VIII Deficiency Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Factor VIII Deficiency Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Factor VIII Deficiency Treatment development in United States, Europe and China.

The key players covered in this study
Pfizer
Shire
Bayer HealthCare
CSL
Grifols
Novo Nordisk
F. Hoffmann-La Roche
Kedrion
Octapharma
Biogen Idec
BioMarin Pharmaceutical
Sangamo Therapeutics
Spark Therapeutics
Swedish Orphan Biovitrum
Uniqure NV
Amarna Therapeutics
Dimension Therapeutics

Market segment by Type, the product can be split into
Hemophilia A Drugs
Hemophilia A Inhibitors Treatment
Von Willebrand Disease Treatment

Market segment by Application, split into
Hospitals
Clinics
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Factor VIII Deficiency Treatment status, future forecast, growth opportunity, key market and key players.
To present the Factor VIII Deficiency Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Factor VIII Deficiency Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Factor VIII Deficiency Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Hemophilia A Drugs
1.4.3 Hemophilia A Inhibitors Treatment
1.4.4 Von Willebrand Disease Treatment
1.5 Market by Application
1.5.1 Global Factor VIII Deficiency Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Factor VIII Deficiency Treatment Market Size
2.2 Factor VIII Deficiency Treatment Growth Trends by Regions
2.2.1 Factor VIII Deficiency Treatment Market Size by Regions (2014-2025)
2.2.2 Factor VIII Deficiency Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Factor VIII Deficiency Treatment Market Size by Manufacturers
3.1.1 Global Factor VIII Deficiency Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Factor VIII Deficiency Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Factor VIII Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Factor VIII Deficiency Treatment Key Players Head office and Area Served
3.3 Key Players Factor VIII Deficiency Treatment Product/Solution/Service
3.4 Date of Enter into Factor VIII Deficiency Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Factor VIII Deficiency Treatment Market Size by Type (2014-2019)
4.2 Global Factor VIII Deficiency Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Factor VIII Deficiency Treatment Market Size (2014-2019)
5.2 Factor VIII Deficiency Treatment Key Players in United States
5.3 United States Factor VIII Deficiency Treatment Market Size by Type
5.4 United States Factor VIII Deficiency Treatment Market Size by Application

6 Europe
6.1 Europe Factor VIII Deficiency Treatment Market Size (2014-2019)
6.2 Factor VIII Deficiency Treatment Key Players in Europe
6.3 Europe Factor VIII Deficiency Treatment Market Size by Type
6.4 Europe Factor VIII Deficiency Treatment Market Size by Application

7 China
7.1 China Factor VIII Deficiency Treatment Market Size (2014-2019)
7.2 Factor VIII Deficiency Treatment Key Players in China
7.3 China Factor VIII Deficiency Treatment Market Size by Type
7.4 China Factor VIII Deficiency Treatment Market Size by Application

8 Japan
8.1 Japan Factor VIII Deficiency Treatment Market Size (2014-2019)
8.2 Factor VIII Deficiency Treatment Key Players in Japan
8.3 Japan Factor VIII Deficiency Treatment Market Size by Type
8.4 Japan Factor VIII Deficiency Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Factor VIII Deficiency Treatment Market Size (2014-2019)
9.2 Factor VIII Deficiency Treatment Key Players in Southeast Asia
9.3 Southeast Asia Factor VIII Deficiency Treatment Market Size by Type
9.4 Southeast Asia Factor VIII Deficiency Treatment Market Size by Application

10 India
10.1 India Factor VIII Deficiency Treatment Market Size (2014-2019)
10.2 Factor VIII Deficiency Treatment Key Players in India
10.3 India Factor VIII Deficiency Treatment Market Size by Type
10.4 India Factor VIII Deficiency Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Factor VIII Deficiency Treatment Market Size (2014-2019)
11.2 Factor VIII Deficiency Treatment Key Players in Central & South America
11.3 Central & South America Factor VIII Deficiency Treatment Market Size by Type
11.4 Central & South America Factor VIII Deficiency Treatment Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Factor VIII Deficiency Treatment Introduction
12.1.4 Pfizer Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Shire
12.2.1 Shire Company Details
12.2.2 Company Description and Business Overview
12.2.3 Factor VIII Deficiency Treatment Introduction
12.2.4 Shire Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.2.5 Shire Recent Development
12.3 Bayer HealthCare
12.3.1 Bayer HealthCare Company Details
12.3.2 Company Description and Business Overview
12.3.3 Factor VIII Deficiency Treatment Introduction
12.3.4 Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.3.5 Bayer HealthCare Recent Development
12.4 CSL
12.4.1 CSL Company Details
12.4.2 Company Description and Business Overview
12.4.3 Factor VIII Deficiency Treatment Introduction
12.4.4 CSL Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.4.5 CSL Recent Development
12.5 Grifols
12.5.1 Grifols Company Details
12.5.2 Company Description and Business Overview
12.5.3 Factor VIII Deficiency Treatment Introduction
12.5.4 Grifols Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.5.5 Grifols Recent Development
12.6 Novo Nordisk
12.6.1 Novo Nordisk Company Details
12.6.2 Company Description and Business Overview
12.6.3 Factor VIII Deficiency Treatment Introduction
12.6.4 Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.6.5 Novo Nordisk Recent Development
12.7 F. Hoffmann-La Roche
12.7.1 F. Hoffmann-La Roche Company Details
12.7.2 Company Description and Business Overview
12.7.3 Factor VIII Deficiency Treatment Introduction
12.7.4 F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.7.5 F. Hoffmann-La Roche Recent Development
12.8 Kedrion
12.8.1 Kedrion Company Details
12.8.2 Company Description and Business Overview
12.8.3 Factor VIII Deficiency Treatment Introduction
12.8.4 Kedrion Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.8.5 Kedrion Recent Development
12.9 Octapharma
12.9.1 Octapharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 Factor VIII Deficiency Treatment Introduction
12.9.4 Octapharma Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.9.5 Octapharma Recent Development
12.10 Biogen Idec
12.10.1 Biogen Idec Company Details
12.10.2 Company Description and Business Overview
12.10.3 Factor VIII Deficiency Treatment Introduction
12.10.4 Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.10.5 Biogen Idec Recent Development
12.11 BioMarin Pharmaceutical
12.12 Sangamo Therapeutics
12.13 Spark Therapeutics
12.14 Swedish Orphan Biovitrum
12.15 Uniqure NV
12.16 Amarna Therapeutics
12.17 Dimension Therapeutics

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details